Angang Yang

19PUBLICATIONS
17CO-AUTHORS
Genomics and transcriptomicsMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 18, 2026
A Real-Data-Driven Framework for Evaluating Differential Transcript Usage Methods Across Long-Read Bulk, Single-Cell, and Spatial Transcriptomics.

|Jul 30, 2026
p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.

|Jan 08, 2026
METTL3 abrogation promotes glioma progression through regulating the ISG15-FASN axis-mediated lipid metabolism in macrophages.

Huilong Yin, Xiaoyi Yu, Chenglong Hu

|Jan 26, 2025
Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair.

Yuchen Wei, Peng Wang, Jianhui Zhao

|Jan 14, 2025
Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells.

Pengju Wang, Yiyi Wang, Xiaojuan Zhao

|Oct 30, 2024
Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumors.

Rui Zheng, Kuo Shen, Sixin Liang

Pageof 4

Frequent Collaborators

10 joint publications

Rui Zhang

4 joint publications

Bo Yan

3 joint publications

Jun Liu

3 joint publications

Huilong Yin